Advertisement
Research Article Free access | 10.1172/JCI112495
Find articles by Dinarello, C. in: JCI | PubMed | Google Scholar
Find articles by Cannon, J. in: JCI | PubMed | Google Scholar
Find articles by Mier, J. in: JCI | PubMed | Google Scholar
Find articles by Bernheim, H. in: JCI | PubMed | Google Scholar
Find articles by LoPreste, G. in: JCI | PubMed | Google Scholar
Find articles by Lynn, D. in: JCI | PubMed | Google Scholar
Find articles by Love, R. in: JCI | PubMed | Google Scholar
Find articles by Webb, A. in: JCI | PubMed | Google Scholar
Find articles by Auron, P. in: JCI | PubMed | Google Scholar
Find articles by Reuben, R. in: JCI | PubMed | Google Scholar
Published June 1, 1986 - More info
Complementary DNA coding for human monocyte interleukin 1 (IL-1), pI 7 form, was expressed in Escherichia coli. During purification, IL-1 activity on murine T cells was associated with the recombinant protein. Homogeneous human recombinant IL-1 (hrIL-1) was tested in several assays to demonstrate the immunological and inflammatory properties attributed to this molecule. hrIL-1 induced proliferative responses in a cloned murine T cell in the presence of suboptimal concentrations of mitogen, whereas no effect was observed with hrIL-1 alone. At concentrations of 0.05 ng/ml, hrIL-1 doubled the response to mitogen (5 X 10(6) half maximal units/mg). Human peripheral blood T cells depleted of adherent cells underwent a blastogenic response and released interleukin 2 in the presence of hrIL-1 and mitogen. hrIL-1 was a potent inflammatory agent by its ability to induce human dermal fibroblast prostaglandin E2 production in vitro and to produce monophasic (endogenous pyrogen) fever when injected into rabbits or endotoxin-resistant mice. These studies establish that the dominant pI 7 form of recombinant human IL-1 possesses immunological and inflammatory properties and acts on the central nervous system to produce fever.
Images.